tradingkey.logo
tradingkey.logo
Search

Qiagen NV

QGEN
Add to Watchlist
40.100USD
+0.980+2.50%
Close 07/02, 13:00ETQuotes delayed by 15 min
8.27BMarket Cap
21.46P/E TTM

TradingKey Stock Score of Qiagen NV

Currency: USD Updated: 2026-07-02

Key Insights

Qiagen NV's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 12 out of 387 in the Biotechnology & Medical Research industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 44.45.In the medium term, the stock price is expected to remain stable.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Qiagen NV's Score

Industry at a Glance

Industry Ranking
12 / 387
Overall Ranking
58 / 4565
Industry
Biotechnology & Medical Research

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

Qiagen NV Highlights

StrengthsRisks
Qiagen NV is a holding company based in the Netherlands. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The Company's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 2.09B.
Undervalued
The company’s latest PE is 21.46, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 161.40M shares, decreasing 15.71% quarter-over-quarter.
Held by Bill Nygren | OAKMX
Star Investor Bill Nygren | OAKMX holds 93.00K shares of this stock.

Analyst Rating

Based on 16 analysts
Buy
Current Rating
44.448
Target Price
+13.59%
Upside Space

FAQs

How does TradingKey generate the Stock Score of Qiagen NV?

The TradingKey Stock Score provides a comprehensive assessment of Qiagen NV based on 34 indicators derived from over 100 underlying data points.
These indicators are categorised into six key dimensions: financial health, company profile, earnings forecasts, price momentum, institutional confidence, and risk assessment, collectively providing investors with a thorough analysis of Qiagen NV’s performance and outlook.

How do we generate the financial health score of Qiagen NV?

To generate the financial health score of Qiagen NV, we analyse various key financial indicators across several core dimensions, including financial fundamentals, earnings quality, operational efficiency, growth potential, and shareholder returns.
By integrating these comprehensive data, the financial health score not only reflects Qiagen NV's overall stability, operational efficiency, and growth potential but also captures the investment returns delivered to shareholders. This score aims to support rational decision-making for investors and other stakeholders. A higher score indicates a better financial health of Qiagen NV.

How do we generate the company valuation score of Qiagen NV?

To generate the company valuation score of Qiagen NV, we use several key financial ratios, including P/E, P/B, P/S, and P/CF. These metrics compare Qiagen NV’s market value to its earnings, assets, sales, and cash flow, serving as core indicators for assessing company value.
By analysing these ratios in an all-round manner, the valuation score reflects not only the market’s current perception of Qiagen NV’s value but also its future profitability and growth potential, thereby supporting more informed investment decisions. A higher score indicates a fairer valuation of Qiagen NV.

How do we generate the earnings forecast score of Qiagen NV?

To calculate the earnings forecast score of Qiagen NV, we consider various key indicators such as analyst ratings, financial forecasts, support and resistance levels, and peer comparisons:
Current ratings and price targets directly reflect analysts’ expectations, while the upside space indicates their views on the stock’s growth potential.
Financial metrics like earnings per share (EPS), revenue, net income, and earnings before interest and taxes (EBIT) are core measures for assessing profitability.
By analysing the high, median, and low ranges of the target price, we can identify price trends and determine key support and resistance levels.
Comparing these indicators against peers provides context for the stock’s performance and helps anchor more realistic expectations.
These factors together form a comprehensive earnings forecast score that accurately reflects the stock’s expected financial performance and growth potential. A higher score suggests that analysts have a more optimistic outlook on Qiagen NV’s future.

How do we generate the price momentum score of Qiagen NV?

When generating the price momentum score for Qiagen NV, we examine momentum indicators including support and resistance levels as well as volume metrics.
Support levels represent price points where buying interest is strong enough to prevent further declines, while resistance levels indicate prices where selling pressure may hinder upward movement. By analysing typical price volume alongside total volume, we assess overall market activity and liquidity. These indicators help identify price trends and potential shifts, enabling more accurate predictions of future earnings.
This comprehensive approach can reflect market sentiment and enable rational forecasts of Qiagen NV’s prices. A higher score indicates a more stable short-term price trend for Qiagen NV.

How do we generate the institutional confidence score of Qiagen NV?

To generate the institutional confidence score of Qiagen NV, we analyse both the proportion of shares held by institutions and the number of shares they own. A higher institutional ownership percentage indicates strong confidence of professional investors, which is generally a positive signal about Qiagen NV’s potential. By examining the number of shares held, we gain deeper insight into institutions’ commitment and attitude toward the stock, as institutional investors typically conduct thorough analysis before making investment decisions. Understanding institutional confidence helps us refine earnings forecasts and provides a more reliable perspective on the company’s future performance and market stability. A higher score indicates greater institutional endorsement of Qiagen NV.

How do we generate the risk management score of Qiagen NV?

To assess the risk management score of Qiagen NV, we examine multiple key indicators related to returns, risk, volatility, and liquidity.
The highest and lowest daily returns reflect the potential size of gains and losses, while the Sharpe ratio measures risk-adjusted return performance. On the risk side, we analyse maximum drawdown and the return-to-drawdown ratio to identify extreme loss scenarios. Skewness helps assess the distribution of returns and whether performance may be biased. Volatility indicators—such as realised volatility and standardised true range—reveal price fluctuations. Downside risk-adjusted returns provide insight into potential losses and gains. Lastly, liquidity metrics like average turnover rate and turnover deviation indicate how actively the stock is traded.
These indicators together provide a multi-dimensional understanding of Qiagen NV’s risk-return profile, serving as core factors of the risk management score. A higher score indicates lower risk on the side of Qiagen NV.